Search

A study of nearly 900 kidney cancer tumors has identified previously unknown biomarkers that correlate with better treatment responses to immunotherapy and targeted therapy.

… Monday, September 7, 2020 Summary An international team of investigators led by Memorial Sloan Kettering’s Robert Motzer has identified biological attributes of kidney cancer tumors that correlate with better responses to immunotherapies and targeted therapies. Treatments for kidney cancer have improved

On December 4, 2024, the U.S. Food and Drug Administration granted accelerated approval to zenocutuzumab (Bizengri®), the first approved systemic therapy for patients with advanced, unresectable, or metastatic non-small cell lung cancer (NSCLC) harboring a neuregulin 1 (NRG1) fusion and pancreatic adenocarcinoma harboring a (NRG1) fusion.

… Thursday, February 6, 2025 Zenocutuzumab is a novel bispecific antibody designed by Merus, N.V. In a multicenter global phase 2 clinical trial led by MSK gynecologic medical oncologist and early drug development specialist Alison Schram, MD , the drug demonstrated durable antitumor activity and met prespecified

As we approach the end of 2019, learn about some of the biggest advances in clinical research made this year at MSK.

… Thursday, December 12, 2019 In 2019, MSK clinical researchers made several major discoveries that will improve the treatment of cancer and guide the development of new therapies. Many of these studies were made possible by large and small philanthropic donations, which allow researchers to pursue innovative

Fourteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 14, 2025, as part of Memorial Sloan Kettering’s 46th annual academic convocation.

… Monday, May 12, 2025 On May 14, 2025, 14 new PhD scientists will officially receive their degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) . The graduates will receive their diplomas as part of the 46th annual academic convocation and commencement ceremony held at

Degrees were presented and awards were given at the 35th annual ceremony held on May 14.

… Friday, May 23, 2014 Summary Degrees were presented and awards were given at the 35th annual ceremony held on May 14. President and CEO Craig Thompson welcomes attendees to the 35th annual Academic Convocation ceremony and Commencement for students from the Louis V. Gerstner, Jr. Graduate School of Biomedical

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement today regarding financial results for the six months ended June 30, 2023.

… Tuesday, August 15, 2023 Memorial Sloan Kettering Cancer Center (MSK) issued the following statement today regarding financial results for the six months ended June 30, 2023:    MSK’s financial performance for the six months ended June 30, 2023, demonstrated continued improvement in operating results

… Tuesday, February 8, 2022 2022 Black History Month Employee Profiles Carl Sanon, Assistant Manager, Outpatient Operations, Ralph Lauren Center When Carl was a junior at Binghamton University, he received an opportunity to work at MSK as a summer support intern. Initially, he saw it as a chance to make

While numerous summer student internships were cancelled this year due to the pandemic, MSK quickly modified many of our summer student programs to enroll more than 300 interns from around the world – both virtually and in-person.

… Monday, August 24, 2020 While numerous summer internships in the United States and abroad were cancelled this year due to the pandemic, Memorial Sloan Kettering (MSK) has kept many internship programs running – both virtually and in-person. This summer, more than 300 interns from around the world were

A sensitive assay for detecting tumor DNA in the blood performed well in patients and may herald the development of a blood test for cancer screening.

… Saturday, June 3, 2017 Summary Sophisticated laboratory assays for detecting and sequencing small amounts of DNA are revolutionizing biology and medicine. At ASCO, the world’s largest cancer meeting, scientists from MSK are reporting that a new and highly sensitive genomic sequencing assay can be used

This CAR T Update Part 2 summarizes the unique challenges with using CARS to defeat solid tumors, and how learning from preclinical and clinical research in hematologic malignancies is informing new strategies and research efforts.

… Thursday, June 11, 2020 New and emerging information about chimeric antigen receptor (CAR) T cell therapy in the setting of hematologic malignancies is informing strategies for overcoming obstacles in solid tumors. In our paper, published recently in the journal Expert Review of Hematology , we discuss